The Tuberous Sclerosis Complex Research Program (TSCRP) is accepting applications for the fiscal year 2017 grant cycle. Letters of intent are due July 11, 2017.
Three award mechanisms are available this year:
- Exploration – Hypothesis Development Award (up to $150,000 in direct costs over two years)
- Idea Development Award (up to $450,000 in direct costs over three years)
- Clinical Translational Research Award (up to $600,000 in direct costs over three years)
TSCRP is part of the Congressionally Directed Medical Research Programs (CDMRPs) at the United States Department of Defense. Please see the TSCRP website for more information on these three funding mechanisms.